ROLE FOR SEROTONIN(3) RECEPTORS IN THE CONTROL OF ADRENOCORTICOTROPIC HORMONE-RELEASE FROM RAT PITUITARY CELL-CULTURES

被引:31
作者
CALOGERO, AE
BAGDY, G
BURRELLO, N
POLOSA, P
DAGATA, R
机构
[1] UNIV CATANIA,DEPT INTERNAL MED,CATANIA,ITALY
[2] NATL INST PSYCHIAT & NEUROL,BUDAPEST,HUNGARY
[3] UNIV CATANIA,CHAIR ANDROL,CATANIA,ITALY
关键词
D O I
10.1530/eje.0.1330251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although several serotonin (5-HT) receptor types have been shown capable of stimulating the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, relatively little is known about the role of the 5-HT3 receptor, a receptor that has generated a great deal of interest for its involvement in many behavioral and therapeutic effects. Hence, in this study, we tested the effects of the 5-HT3/4 receptor antagonist 3-tropanyl-indole-3-carboxylate (ICS 205-930) and the selective 5-HT3 receptor antagonist 3-tropanyl-3,5-dichlorobenzoate (MDL 72222) on ACTH release stimulated by 5-HT from primary cultures of rat pituitary cells. Subsequently, we evaluated the effects of the selective 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide (m-CPBG) on basal, corticotropin-releasing hormone (CRH)- and arginine vasopressin (AVP)-stimulated ACTH release. The maximal stimulatory effect of 5-HT (10(-9) mol/l) on ACTH release was antagonized by both ICS 205-930 and MDL 72222, suggesting that 5-HT stimulates basal ACTH release through activation of 5-HT3 receptors. Accordingly, m-CPBG stimulated basal ACTH release in a concentration-dependent fashion. In contrast to 5-HT, m-CPBG did not have any effect on CRH-stimulated ACTH release and inhibited AVP-stimulated ACTH release in a concentration-dependent manner. These data suggest that the 5-HT3 receptor is involved in the release of ACTH from the pituitary gland in vitro.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 25 条
[1]   EVIDENCE FOR CENTRAL AND PERIPHERAL SEROTONERGIC CONTROL OF CORTICOSTERONE SECRETION IN THE CONSCIOUS RAT [J].
ALPER, RH .
NEUROENDOCRINOLOGY, 1990, 51 (03) :255-260
[2]   HYPOTHALAMIC PARAVENTRICULAR NUCLEUS LESIONS DIFFERENTIALLY AFFECT SEROTONIN-1A (5-HT1A) AND 5-HT2 RECEPTOR AGONIST-INDUCED OXYTOCIN, PROLACTIN, AND CORTICOSTERONE RESPONSES [J].
BAGDY, G ;
MAKARA, GB .
ENDOCRINOLOGY, 1994, 134 (03) :1127-1131
[3]   SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS [J].
BAGDY, G ;
CALOGERO, AE ;
MURPHY, DL ;
SZEMEREDI, K .
ENDOCRINOLOGY, 1989, 125 (05) :2664-2669
[4]   EFFECTS OF SEROTONERGIC AGONISTS AND ANTAGONISTS ON CORTICOTROPIN-RELEASING HORMONE-SECRETION BY EXPLANTED RAT HYPOTHALAMI [J].
CALOGERO, AE ;
BERNARDINI, R ;
MARGIORIS, AN ;
BAGDY, G ;
GALLUCCI, WT ;
MUNSON, PJ ;
TAMARKIN, L ;
TOMAI, TP ;
BRADY, L ;
GOLD, PW ;
CHROUSOS, GP .
PEPTIDES, 1989, 10 (01) :189-200
[5]   MECHANISMS OF SEROTONIN RECEPTOR AGONIST-INDUCED ACTIVATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN THE RAT [J].
CALOGERO, AE ;
BAGDY, G ;
SZEMEREDI, K ;
TARTAGLIA, ME ;
GOLD, PW ;
CHROUSOS, GP .
ENDOCRINOLOGY, 1990, 126 (04) :1888-1894
[6]   EFFECT OF SELECTIVE SEROTONIN AGONISTS ON BASAL, CORTICOTROPIN-RELEASING HORMONE-INDUCED AND VASOPRESSIN-INDUCED ACTH RELEASE INVITRO FROM RAT PITUITARY-CELLS [J].
CALOGERO, AE ;
BAGDY, G ;
MONCADA, ML ;
DAGATA, R .
JOURNAL OF ENDOCRINOLOGY, 1993, 136 (03) :381-387
[7]  
ELMESTIKAWY S, 1993, EUR NEUROPSYCHOPHARM, V3, P245
[8]  
Fuller R.W., 1988, ADV DRUG RES, V17, P349
[9]  
FULLER RW, 1992, FRONT NEUROENDOCRIN, V13, P250
[10]  
GARTSIDE SE, 1990, EUR J PHARMACOL, V179, P130